Sign inGet started

Gollust Keith R

Insider CIK 1325712 · SNTA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MDGL MADRIGAL PHARMACEUTICALS, A Award deriv2022-06-162022-06-219,470— $09,470SEC↗
MDGL MADRIGAL PHARMACEUTICALS, A Award deriv2021-06-172021-06-2112,489— $012,489SEC↗
MDGL MADRIGAL PHARMACEUTICALS, A Award deriv2020-06-172020-06-186,000— $06,000SEC↗
MDGL MADRIGAL PHARMACEUTICALS, A Award deriv2019-06-272019-07-0110,000— $010,000SEC↗
MDGL MADRIGAL PHARMACEUTICALS, A Award deriv2018-06-192018-06-2110,000— $010,000SEC↗
MDGL MADRIGAL PHARMACEUTICALS, A Award deriv2017-06-292017-06-3010,000— $010,000SEC↗
MDGL MADRIGAL PHARMACEUTICALS, A Award deriv2016-07-222016-10-2420,000— $020,000SEC↗
MDGL MADRIGAL PHARMACEUTICALS, A Award deriv2016-07-222016-11-0420,000— $020,000SEC↗
SNTA SYNTA PHARMACEUTICALS CORP S Sale2015-12-142015-12-15300,000$0.32 $96.0K1,539,169SEC↗
SNTA SYNTA PHARMACEUTICALS CORP S Sale2015-12-112015-12-15300,000$0.37 $111.0K1,839,169SEC↗
SNTA SYNTA PHARMACEUTICALS CORP S Sale2015-12-092015-12-09145,892$0.38 $55.4K2,139,169SEC↗
SNTA SYNTA PHARMACEUTICALS CORP S Sale2015-12-082015-12-09300,000$0.38 $114.0K2,285,061SEC↗
SNTA SYNTA PHARMACEUTICALS CORP S Sale2015-12-072015-12-09300,000$0.39 $117.0K2,585,061SEC↗
SNTA SYNTA PHARMACEUTICALS CORP S Sale2015-11-172015-11-19100,000$0.41 $41.0K2,885,061SEC↗
SNTA SYNTA PHARMACEUTICALS CORP S Sale2015-11-102015-11-12188,322$0.55 $103.6K2,985,061SEC↗
SNTA SYNTA PHARMACEUTICALS CORP S Sale2015-11-102015-11-13188,322$0.55 $103.6K2,985,061SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award deriv2015-07-012015-07-0615,000— $015,000SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award deriv2015-07-012015-07-0620,000— $020,000SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2015-07-012015-07-0622,727— $0374,493SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2015-07-012015-07-064,545— $0401,764SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2015-07-012015-07-064,545— $0397,219SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2015-07-012015-07-064,545— $0392,674SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2015-07-012015-07-0613,636— $0388,129SEC↗
SNTA SYNTA PHARMACEUTICALS CORP P Buy2015-04-062015-04-08350,000$1.75 $612.5K3,173,383SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award deriv2014-07-012014-07-034,500— $04,500SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award deriv2014-07-012014-07-0310,000— $010,000SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2014-07-012014-07-039,756— $0342,011SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2014-07-012014-07-031,219— $0351,766SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2014-07-012014-07-034,878— $0346,889SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2014-07-012014-07-032,439— $0349,328SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2014-07-012014-07-031,219— $0350,547SEC↗
SNTA SYNTA PHARMACEUTICALS CORP P Buy2013-11-132013-11-15150,000$3.75 $562.5K2,823,383SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award deriv2013-07-012013-07-0310,000— $010,000SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award deriv2013-07-012013-07-034,500— $04,500SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2013-07-012013-07-038,000— $0324,255SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2013-07-012013-07-034,000— $0328,255SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2013-07-012013-07-032,000— $0330,255SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2013-07-012013-07-031,000— $0332,255SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2013-07-012013-07-031,000— $0331,255SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise deriv2013-01-232013-01-2475,000— $00SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise deriv2013-01-232013-01-245,500— $00SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise deriv2013-01-232013-01-242,500— $00SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise deriv2013-01-232013-01-245,500— $00SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise deriv2013-01-232013-01-242,250— $02,250SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise deriv2013-01-232013-01-245,000— $05,000SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise deriv2013-01-232013-01-242,500— $00SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise deriv2013-01-232013-01-245,500— $00SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise deriv2013-01-232013-01-242,500— $00SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise deriv2013-01-232013-01-245,500— $00SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise deriv2013-01-232013-01-242,500— $00SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise2013-01-232013-01-242,500$2.38 $6.0K293,005SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise2013-01-232013-01-245,500$2.38 $13.1K290,505SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise2013-01-232013-01-242,500$7.03 $17.6K285,005SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise2013-01-232013-01-245,500$7.03 $38.7K282,505SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise2013-01-232013-01-2475,000$10.84 $813.0K277,005SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise2013-01-232013-01-242,250$5.47 $12.3K316,255SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise2013-01-232013-01-245,000$5.47 $27.4K314,005SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise2013-01-232013-01-242,500$5.09 $12.7K309,005SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise2013-01-232013-01-245,500$5.09 $28.0K306,505SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise2013-01-232013-01-242,500$2.59 $6.5K301,005SEC↗
SNTA SYNTA PHARMACEUTICALS CORP M Exercise2013-01-232013-01-245,500$2.59 $14.2K298,505SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2012-12-122012-12-14175,000$8.60 $1.50M175,000SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2012-12-122012-12-1475,000$8.60 $645.0K2,673,383SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2012-07-252012-07-27770,416$6.49 $5.00M2,598,383SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award deriv2012-07-012012-07-034,500— $04,500SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award deriv2012-07-012012-07-0310,000— $010,000SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2012-07-012012-07-03914— $0202,005SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2012-07-012012-07-03914— $0201,091SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2012-07-012012-07-031,828— $0200,177SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2012-07-012012-07-033,656— $0198,349SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2012-07-012012-07-037,312— $0194,693SEC↗
SNTA SYNTA PHARMACEUTICALS CORP P Buy2012-06-292012-07-02150,000$5.35 $802.5K1,827,967SEC↗